12/12/2023
๐ข ๐๐ฐ๐ฒ๐ง๐ฒ๐ฐ๐ต ๐ถ๐ ๐ฝ๐ฟ๐ผ๐๐ฑ๐น๐ ๐น๐ถ๐๐๐ฒ๐ฑ ๐ถ๐ป ๐๐ ๐๐ฅ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ด๐ฟ๐ผ๐๐ฝ ๐๐ผ ๐ฏ๐ฒ ๐ฎ ๐น๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ด ๐๐ผ๐น๐๐๐ถ๐ผ๐ป ๐ณ๐ผ๐ฟ ๐ฅ๐ฎ๐ฑ๐ถ๐ฎ๐๐ถ๐ผ๐ป ๐๐ฒ๐ฟ๐บ๐ฎ๐๐ถ๐๐ถ๐
AceTech is proud to be listed in @๐๐ป๐๐ฒ๐น๐น๐ฒ๐ฐ๐๐๐ฎ๐น ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ป๐๐ถ๐ด๐ต๐๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต (๐๐ ๐๐ฅ), a global market research and consulting company, covering leading solutions for Radiation Dermatitis. Placing AceTech among leading companies such as Bayer and 3M.
AceTech is offering ๐ฅ๐ฎ๐ฑ๐ถ๐ฎ๐๐ฐ๐ฒ ๐๐๐ฑ๐ฟ๐ผ๐ด๐ฒ๐น, a clear, non-oily, non-adherent hydrogel, serving as a remedy to patients suffering from Radiation Dermatitis side effects.
RadiaAce efficacy superiority in the prevention and treatment of Radiation Dermatitis ๐ถ๐ป ๐ฏ๐ฟ๐ฒ๐ฎ๐๐ ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐๐ over Biafine was recently demonstrated in a study conducted at Assuta Medical Centers, Israel.
Radiation dermatitis, a challenging side effect of Radiation Therapy (RT), profoundly affects the lives of nearly 95% of patients undergoing such treatments. Including a high level of Acemannan active ingredient compound, allows for better results and results achieved.
To learn more about the RadiaAce study and request an introduction meeting, visit our website: https://www.acemanan-tech.com/science-innovation/clinical-research/